Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Key Dates
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
ASX Announcements
Filter by Year:
2023
2022
2021
2020
25-Mar-2021
Change in substantial holding
22-Mar-2021
Proposed issue of Securities - NYR
22-Mar-2021
Nyrada Receives Firm Commitments to Raise A$11 Million
18-Mar-2021
Nyrada Investor Presentation
17-Mar-2021
Trading Halt
5-Mar-2021
Change of Director's Interest Notice - JM
2-Mar-2021
Nyrada Newsletter February 2021
24-Feb-2021
Appendix 3G
24-Feb-2021
Change of Director's Interest Notice - MF
23-Feb-2021
Investor Presentation to Finance News Network CEO Showcase
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
Next